COVID-19 Pill Could Be Available Later This Year: Pfizer CEO
THURSDAY, April 29, 2021 -- A pill to treat COVID-19 is being developed by Pfizer and could be available by the end of the year, company CEO Albert Bourla says.
In March, Pfizer launched an early-stage clinical trial of a new antiviral drug for the coronavirus that causes COVID-19, CBS News reported. The drug reduces the production of enzymes the virus needs to multiply in human cells.
If clinical trials are successful and the U.S. Food and Drug Administration approves the drug, it could be available across the United States later in 2021, Bourla told CNBC on Tuesday, CBS News reported.
Last month, Mikael Dolsten, M.D., chief scientific officer and president, worldwide research, development, and medical of Pfizer, said it is possible that the new drug could be prescribed "at the first sign of infection, without requiring that patients are hospitalized or in critical care."
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
THURSDAY, May 13, 2021 -- An artificial intelligence (AI) system can predict deterioration of COVID-19 patients in the emergency department, according to a study published online...
THURSDAY, May 13, 2021 -- In a decision that clears the way for schools to reopen safely next fall, U.S. health officials on Wednesday gave their final stamp of approval for the...
THURSDAY, May 13, 2021 -- Neurological manifestations are common among patients hospitalized with COVID-19 and are associated with an increased risk for in-hospital mortality,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.